Navigation Links
$9 Million Committed to Bolster Worldwide Measles Initiative
Date:9/25/2008

The Vodafone Foundation-United Nations Foundation Partnership, Merck & Co., Inc., the Kessler Family Foundation and the American Red Cross announce support for partnership at Clinton Global Initiative

Washington, D.C. (PRWEB) September 25, 2008 -- www.measlesinitiative.org [The Measles Initiative] announced today $9 million worth of donations from the http://www.unfoundation.org/global-issues/technology/ [Vodafone Foundation-United Nations Foundation] Technology Partnership, Merck & Co, Inc., the Kessler Family Foundation and the American Red Cross. This support will help to enable the Measles Initiative to vaccinate an estimated 76 million children in about 25 countries during 2009.

"Measles deaths have declined 68% globally since the Measles Initiative partnership began in 2001," says Michele Kessler, American Red Cross Global Measles Ambassador and founder of the Kessler Family Foundation. "But a funding gap for 2009 means we are in danger of losing our momentum. These commitments will help reduce that gap and allow us to continue saving lives."

The Measles Initiative - an innovative global health partnership led by the American Red Cross, the U.S. Centers for Disease Control and Prevention, UNICEF, the United Nations Foundation and World Health Organization - is working to reduce measles mortality in 2010 by 90% (compared to 2000) and support U.N. Millennium Development Goal #4 of reducing under-five mortality rates by two-thirds between 1990 and 2015.

"Already the Measles Initiative has saved nearly 3 million children; but this work is not done and we are committed to helping it succeed," said Claire Thwaites, head of the Vodafone Foundation-United Nations Foundation Technology Partnership, which is committing $6 million over 3 years to support the initiative.

"The UN Foundation is so proud to be part of this rema
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
3. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
4. 1.5 million children could be saved
5. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
6. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
7. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
8. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
9. £5 million investment in personalized medicines to cut patient deaths
10. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
$9 Million Committed to Bolster Worldwide Measles Initiative 
$9 Million Committed to Bolster Worldwide Measles Initiative
(Date:11/27/2009)...may reduce future disease burden, researchers say ...Encouraging city dwellers to walk and bicycle inst...health benefits than increased used of low-emissio...study compared the projected health effects in 203...r London, England, and Delhi, India: business-as-...
(Date:11/27/2009)...ers who use medical load cells at the heart of the...ging in technology partner Flintec early in the de...ical manufacturers are calling in Flintec load cel...ensuring that progress will not be constrained by ...technology. , (PRWEB) Nov...
(Date:11/26/2009)...te (TM) has been shown in studies to be effective ...ed by an overload of copper, and certain metastati...r, is known about how the drug works at the molecu...versity researchers now has provided an invaluable... to copper-loaded metallochaperones. The drug sequ...
(Date:11/26/2009)...tal (RTDental), a leading dental group practice in...sion of its services to include LUMINEERS by a cer... Durham, NC (PRWEB) -- Res...Dr. Doug Macmillan, an experienced LUMINEERS Den...aining seminar. RTDental’s ability to fulfi...
(Date:11/25/2009)...wswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. ...will host two investor events in December: ,, ....m. CT/10:00 a.m. ET ,, Principal investigato...filzomib in relapsed and/or refractory multiple my... Hematology (ASH) Annual Meeting and Exposition in...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...sis by the Health Department and the consequent qu...y in New York heavily. It has to cough up $75,000... officials ordered Maureen Ryan, 64, a nursing cas...ounty Attorney Lori Alesio and Ryan's lawyer, Kevi...
...ildren's Research Hospital have discovered inherit...with acute lymphoblastic leukemia (ALL) susceptib...y medications. The researchers showed that these v...o have its intended effect). The findings,...
...or patching holes in the heart may make it possibl...d others to regain enough strength to safely unde...a study reported at the 30th Annual Scientific Ses...r septal defects(VSDs)or ruptures in the wall betw...
...e Minister, Dr. Anbumani Ramados, speaking at the ...today , said that under the National Rural Health ... 200,000 nursing personnel to provide comprehensiv...tional nursing training institutions. Welcoming th...
...Spears' come-back album will supposedly not talk a...st few months but will instead "celebrate womanhoo... the songs, said the album is not going to be abou...ther way. She didn't let any of her personal life ...
...rs when he taunted supermodel Kate Moss and asked ...h. Moss reportedly walked past the boy in a New ...eports mirror.co.uk. The schoolboy, who had been w...mous women being heckled by a fresh-faced schoolbo...
Other Medicine News:Health News:US County to Compensate Woman Wrongly Quarantined for TB 2Health News:Inherited Genes Linked to Toxicity of Leukemia Therapy 2Health News:Novel Catheter Technique Successfully Patches Holes in the Heart 2Health News:Novel Catheter Technique Successfully Patches Holes in the Heart 3
(Date:11/25/2009)... The FDA granted traditional approv...-nucleoside reverse transcriptase inhibitor (NNRTI...ted for use in treatment-experienced adults who ar...s resistant to an NNRTI and other antiretroviral (... 48-week data from two Phase 3 studies known as DU...
(Date:11/25/2009)... 25 Regado Biosciences, a privatel...mbotic aptamers with active control agents, announ... be presenting at the Piper Jaffray 21st Annual He...in New York City. Dr. Mazzo,s presentation will b... will include an overview of the Company,s pipelin...
(Date:11/25/2009)... Abaxis, Inc. (Nasdaq: ...oint-of-care blood analysis systems, announced tod...ve officer, will present at the 21st Annual Piper ...ber 2, 2009 at 2:00 p.m. ET. The conference will b...ty. ,, About Abaxis ,, Abaxis develops, m...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2New synthetic molecules trigger immune response to HIV and prostate cancer 10644 1New synthetic molecules trigger immune response to HIV and prostate cancer 10644 2Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 1Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 2Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 3Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 4Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 5Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 6Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 7Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 14742 1Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 14742 2
...g, SOMERSET, N.J., April 14 Alfacell Corporation...ee with the University of,Pennsylvania has reporte...,promising radiation sensitizer for lung cancer tr...o and in vitro data in a poster at the 2008 Americ...eting being held April 12 -,16 in San Diego., In ...
...il 14, at 8:30 a.m. E.T. at ...ril 14 Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ...ase 2 open-label extension (OLE) study of mipomers...(FH). In FH patients exposed to,mipomersen for as ...continues to be encouraging. Reductions in LDL-cho...
Other Medicine Technology:Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment 2Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment 3Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 2Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 3Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 4Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 5Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 6
...grade Holter Monitoring System, equipped with the ... ST analysis algorithm, Heart Rate Variability ana...cilities with an Epicardia System in place have co...hem to suit their needs, and managing their data. ...
...Zeiss Meditec product, designed to make the correc...iendly and individual. All the parameters of this ...reasing efficiency, achieving optimum treatment re...s here are the extremely fast ablation, customized...
R Series Code-Ready Defibrillator
TandemHeart Escort Controller
Medicine Products: